217 related articles for article (PubMed ID: 15111500)
1. Interleukin-4 but not interleukin-10 protects against spontaneous and recurrent type 1 diabetes by activated CD1d-restricted invariant natural killer T-cells.
Mi QS; Ly D; Zucker P; McGarry M; Delovitch TL
Diabetes; 2004 May; 53(5):1303-10. PubMed ID: 15111500
[TBL] [Abstract][Full Text] [Related]
2. Activation of natural killer T cells by alpha-galactosylceramide treatment prevents the onset and recurrence of autoimmune Type 1 diabetes.
Sharif S; Arreaza GA; Zucker P; Mi QS; Sondhi J; Naidenko OV; Kronenberg M; Koezuka Y; Delovitch TL; Gombert JM; Leite-De-Moraes M; Gouarin C; Zhu R; Hameg A; Nakayama T; Taniguchi M; Lepault F; Lehuen A; Bach JF; Herbelin A
Nat Med; 2001 Sep; 7(9):1057-62. PubMed ID: 11533711
[TBL] [Abstract][Full Text] [Related]
3. Protection from type 1 diabetes by invariant NK T cells requires the activity of CD4+CD25+ regulatory T cells.
Ly D; Mi QS; Hussain S; Delovitch TL
J Immunol; 2006 Sep; 177(6):3695-704. PubMed ID: 16951329
[TBL] [Abstract][Full Text] [Related]
4. CD1d-restricted NKT regulatory cells: functional genomic analyses provide new insights into the mechanisms of protection against Type 1 diabetes.
Mi QS; Meagher C; Delovitch TL
Novartis Found Symp; 2003; 252():146-60; discussion 160-4, 203-10. PubMed ID: 14609217
[TBL] [Abstract][Full Text] [Related]
5. Up-regulation of CD1d expression restores the immunoregulatory function of NKT cells and prevents autoimmune diabetes in nonobese diabetic mice.
Falcone M; Facciotti F; Ghidoli N; Monti P; Olivieri S; Zaccagnino L; Bonifacio E; Casorati G; Sanvito F; Sarvetnick N
J Immunol; 2004 May; 172(10):5908-16. PubMed ID: 15128771
[TBL] [Abstract][Full Text] [Related]
6. Activation of CD1d-restricted T cells protects NOD mice from developing diabetes by regulating dendritic cell subsets.
Naumov YN; Bahjat KS; Gausling R; Abraham R; Exley MA; Koezuka Y; Balk SB; Strominger JL; Clare-Salzer M; Wilson SB
Proc Natl Acad Sci U S A; 2001 Nov; 98(24):13838-43. PubMed ID: 11707602
[TBL] [Abstract][Full Text] [Related]
7. Activation of human invariant natural killer T cells with a thioglycoside analogue of α-galactosylceramide.
Hogan AE; O'Reilly V; Dunne MR; Dere RT; Zeng SG; O'Brien C; Amu S; Fallon PG; Exley MA; O'Farrelly C; Zhu X; Doherty DG
Clin Immunol; 2011 Aug; 140(2):196-207. PubMed ID: 21493160
[TBL] [Abstract][Full Text] [Related]
8. Role of regulatory invariant CD1d-restricted natural killer T-cells in protection against type 1 diabetes.
Hussain S; Wagner M; Ly D; Delovitch TL
Immunol Res; 2005; 31(3):177-88. PubMed ID: 15888910
[TBL] [Abstract][Full Text] [Related]
9. The natural killer T-cell ligand alpha-galactosylceramide prevents autoimmune diabetes in non-obese diabetic mice.
Hong S; Wilson MT; Serizawa I; Wu L; Singh N; Naidenko OV; Miura T; Haba T; Scherer DC; Wei J; Kronenberg M; Koezuka Y; Van Kaer L
Nat Med; 2001 Sep; 7(9):1052-6. PubMed ID: 11533710
[TBL] [Abstract][Full Text] [Related]
10. Activation of invariant NKT cells confers protection against Chlamydia trachomatis-induced arthritis.
Bharhani MS; Chiu B; Na KS; Inman RD
Int Immunol; 2009 Jul; 21(7):859-70. PubMed ID: 19477915
[TBL] [Abstract][Full Text] [Related]
11. NK T cell-induced protection against diabetes in V alpha 14-J alpha 281 transgenic nonobese diabetic mice is associated with a Th2 shift circumscribed regionally to the islets and functionally to islet autoantigen.
Laloux V; Beaudoin L; Jeske D; Carnaud C; Lehuen A
J Immunol; 2001 Mar; 166(6):3749-56. PubMed ID: 11238616
[TBL] [Abstract][Full Text] [Related]
12. The complementarity determining region 2 of BV8S2 (V beta 8.2) contributes to antigen recognition by rat invariant NKT cell TCR.
Pyz E; Naidenko O; Miyake S; Yamamura T; Berberich I; Cardell S; Kronenberg M; Herrmann T
J Immunol; 2006 Jun; 176(12):7447-55. PubMed ID: 16751390
[TBL] [Abstract][Full Text] [Related]
13. Prevention of type 1 diabetes by invariant NKT cells is independent of peripheral CD1d expression.
Novak J; Beaudoin L; Park S; Griseri T; Teyton L; Bendelac A; Lehuen A
J Immunol; 2007 Feb; 178(3):1332-40. PubMed ID: 17237379
[TBL] [Abstract][Full Text] [Related]
14. Activation of invariant NK T cells protects against experimental rheumatoid arthritis by an IL-10-dependent pathway.
Miellot A; Zhu R; Diem S; Boissier MC; Herbelin A; Bessis N
Eur J Immunol; 2005 Dec; 35(12):3704-13. PubMed ID: 16304639
[TBL] [Abstract][Full Text] [Related]
15. Estrogen Therapy Delays Autoimmune Diabetes and Promotes the Protective Efficiency of Natural Killer T-Cell Activation in Female Nonobese Diabetic Mice.
Gourdy P; Bourgeois EA; Levescot A; Pham L; Riant E; Ahui ML; Damotte D; Gombert JM; Bayard F; Ohlsson C; Arnal JF; Herbelin A
Endocrinology; 2016 Jan; 157(1):258-67. PubMed ID: 26485613
[TBL] [Abstract][Full Text] [Related]
16. Activation of natural killer T cells by alpha-galactosylceramide in the presence of CD1d provides protection against colitis in mice.
Saubermann LJ; Beck P; De Jong YP; Pitman RS; Ryan MS; Kim HS; Exley M; Snapper S; Balk SP; Hagen SJ; Kanauchi O; Motoki K; Sakai T; Terhorst C; Koezuka Y; Podolsky DK; Blumberg RS
Gastroenterology; 2000 Jul; 119(1):119-28. PubMed ID: 10889161
[TBL] [Abstract][Full Text] [Related]
17. CD1d-restricted NKT cell activation enhanced homeostatic proliferation of CD8+ T cells in a manner dependent on IL-4.
Ueda N; Kuki H; Kamimura D; Sawa S; Seino K; Tashiro T; Fushuku K; Taniguchi M; Hirano T; Murakami M
Int Immunol; 2006 Sep; 18(9):1397-404. PubMed ID: 16914507
[TBL] [Abstract][Full Text] [Related]
18. Regulatory natural killer T cells protect against spontaneous and recurrent type 1 diabetes.
Sharif S; Arreaza GA; Zucker P; Delovitch TL
Ann N Y Acad Sci; 2002 Apr; 958():77-88. PubMed ID: 12021086
[TBL] [Abstract][Full Text] [Related]
19. Loss of IL-4 secretion from human type 1a diabetic pancreatic draining lymph node NKT cells.
Kent SC; Chen Y; Clemmings SM; Viglietta V; Kenyon NS; Ricordi C; Hering B; Hafler DA
J Immunol; 2005 Oct; 175(7):4458-64. PubMed ID: 16177088
[TBL] [Abstract][Full Text] [Related]
20. Co-inhibitory roles for glucocorticoid-induced TNF receptor in CD1d-dependent natural killer T cells.
Chen S; Ndhlovu LC; Takahashi T; Takeda K; Ikarashi Y; Kikuchi T; Murata K; Pandolfi PP; Riccardi C; Ono M; Sugamura K; Ishii N
Eur J Immunol; 2008 Aug; 38(8):2229-40. PubMed ID: 18624295
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
